The competing endogenous RNA network (ceRNET) is involved in tumorigenesis and has become a hot spot of research. The ceRNET between CYP4Z1 and the pseudogene CYP4Z2P promotes angiogenesis and mediates tamoxifen resistance in breast cancer. Nevertheless, the effects of this ceRNET on cell apoptosis and related mechanisms remain unclear. In the present study, we found that downregulation of CYP4Z1 or the CYP4Z2P 3 0 -UTR promotes cell apoptosis, mirroring the functions of human telomerase reverse transcriptase (hTERT). Furthermore, the ceRNET between CYP4Z1 and pseudogene CYP4Z2P modulates hTERT expression by operating as a subceRNET for hTERT. Our data demonstrate that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts as a sub-ceRNET for hTERT and, thus, inhibits breast cancer apoptosis.
The competing endogenous RNA network (ceRNET) is involved in tumorigenesis and has become a hot spot of research. The ceRNET between CYP4Z1 and the pseudogene CYP4Z2P promotes angiogenesis and mediates tamoxifen resistance in breast cancer. Nevertheless, the effects of this ceRNET on cell apoptosis and related mechanisms remain unclear. In the present study, we found that downregulation of CYP4Z1 or the CYP4Z2P 3 0 -UTR promotes cell apoptosis, mirroring the functions of human telomerase reverse transcriptase (hTERT). Furthermore, the ceRNET between CYP4Z1 and pseudogene CYP4Z2P modulates hTERT expression by operating as a subceRNET for hTERT. Our data demonstrate that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts as a sub-ceRNET for hTERT and, thus, inhibits breast cancer apoptosis.
Keywords: apoptosis; ceRNET; CYP4Z1; CYP4Z2P; hTERT Breast cancer is the second 'killer' of women worldwide [1] . Although great improvements have been achieved in breast cancer treatment, recurrence or resistance often occurs. Hence, it is important to identify novel biomarkers that combate breast cancer.
Cell apoptosis plays a significant role in all phases of the normal mammary gland development [2] . Aberrations in apoptotic pathways are central to tumorigenesis. Cell apoptosis represents not only a vital target in cancer therapy, but also a unique biomarker opportunity that thus far has been largely unexploited. Therefore, further investigation of apoptosis-related targets is necessary for breast cancer treatment.
Telomerase is highly expressed in more than 85% of cancers but is scarcely expressed in normal somatic cells [3] . Human telomerase reverse transcriptase (hTERT) is the rate-limiting subunit of telomerase and directly determines telomerase activity [4] . Many studies have demonstrated that the activation of telomerase or elevated hTERT expression is related to the occurrence and progression of malignancies [5, 6] . Furthermore, overexpression of hTERT alleviated intracellular reactive oxygen species production and inhibited reactive oxygen species-mediated apoptosis [7] . hTERT potentially mediated apoptotic resistance and blockade of hTERT could enhance chemosensitivity in head and neck cancers [8] . In addition to elongating telomeres, Abbreviations ceRNA; competing endogenous RNA; ceRNET; competing endogenous RNA network; hTERT; human telomerase reverse transcriptase; miRNA; microRNA; MUT; mutated; WT; wild-type.
an anti-apoptotic function was reported in studies of hTERT [9] [10] [11] . However, mechanisms regulating the expression of hTERT in breast cancer have not been formally studied.
MicroRNAs (miRNAs) are small, noncoding RNAs (approximately 22 nucleotides long) that negatively regulate gene expression by binding to the miRNA response elements in mRNA 3 0 -UTR [12] . A competing endogenous RNAs (ceRNA) theory has been proposed in which cross-talk between transcripts occurs as a result of competing for shared miRNA response elements [13] . Various RNA transcripts, such as mRNAs, lincRNAs, circRNAs, pseudogenes such as BRAF [14] and HMGA1 [15] pseudogenes, may modulate the expression of each other by competing for common miRNAs [16] [17] [18] [19] . Notably, perturbations of gene expression can potentially propagate in the competing endogenous RNA network (ceRNET) through a cascade of co-regulated target RNAs and miRNAs that share targets, leading to mutual effects between distant components in the network (i.e. distant ceRNAs or sub-ceRNET) [20] . However, the role of sub-ceRNET in physiological disorders remains poorly defined. A previous study demonstrated that the 3 0 -UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1 [21] . Recently, we found that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acted as a subceRNET to promote CDK3 expression in ER-positive breast cancer [22] . Hence, in the present study, we investigated whether the ceRNET between CYP4Z1 and pseudogene CYP4Z2P plays a role in breast cancer apoptosis.
In the present study, we confirmed that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acted as a sub-ceRNET for hTERT to exert an anti-apoptotic function in breast cancer. To the best of our knowledge, the sub-ceRNET that has been validated has not been reported elsewhere. The present study is the first to demonstrate the anti-apoptotic function of the ceR-NET between CYP4Z1 and pseudogene CYP4Z2P in breast cancer.
Materials and methods

Cell culture
HEK293T cells and human breast cancer cells MCF-7 and MDA-MB-231 were obtained from the ATCC (Manassas, VA, USA) and were maintained in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) and L-15 medium (KeyGEN BioTECH, Nanjing, China) supplemented with 10% fetal bovine serum (Gibco) and antibiotics (80 UÁmL À1 penicillin and 0.08 mgÁmL À1 streptomycin).
The cell lines were incubated in an atmosphere containing 5% CO 2 at 37°C.
Plasmid construction
As for the luciferase reporter plasmids, the full length wildtype (WT) hTERT 3 0 -UTR was amplified using a PCR from human cDNA templates. The primers used were: hTERT-WT-F: 5 0 -GGACTAGTCGAGAGCAGACACCA 
Luciferase reporter assay
The binding sites of miR-125a-3p on hTERT 3 0 -UTR were predicted by bioinformatics websites (www.microrna. org). For miRNA targeting validation studies, HEK 293T cells were seeded in a 24-well plate (4 9 10 4 cells/well) the day prior to transfection and co-transfected with the hTERT-WT or hTERT-MUT plasmid, along with the corresponding miRNA mimic or NC. For validation of ceRNA interaction, MCF-7 and MDA-MB-231 cells were co-transfected with the luciferase reporter constructs (hTERT-WT) and constructs (Z2P-UTR or Z1-UTR) or corresponding siRNAs (si-Z1 or si-Z2P) using the TransIT Ò -BrCa Transfection Reagent. For all of these luciferase reporter assays, a b-gal plasmid was co-transfected and used to normalize the fluorescence values expressed from the pMIR-Report constructs. After transfection for 48 h, cells were lysed in accordance with the manufacturer's instructions (Promega, Madison, WI, USA) and luciferase activity was measured using a Glomax 96 luminometer (Promega). 
Annexin V/PI apoptosis assay
Western blot analysis
Total proteins were extracted from cells using RIPA buffer (Beyotime, Beijing, China). Protein concentrations were quantified using a BCA Protein Assay Kit (Beyotime). Proteins (30 lg) were separated by SDS/PAGE and then transferred to poly(vinylidene difluoride) membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% nonfat dried milk for 1.5 h. Subsequently, membranes were incubated overnight at 4°C with diluted antibodies against hTERT (dilution 1 : 1000; Abgent, Suzhou, China), Bcl-2 (dilution 1 : 1000; Wanlei, Shenyang, China), Bax (dilution 1 : 1000; Abcam, Cambridge, MA, USA), p-Akt (dilution 1 : 1000; Abgent), Akt (dilution 1 : 1000; Abcam), p-ERK1/2 (dilution 1 : 1000; Cell Signaling Technology, Beverly, MA, USA), ERK1/2 (dilution 1 : 1000; Abgent) and b-actin (dilution 1 : 1000; Beyotime) followed by incubation with IgG-HRP secondary antibody (Bio-Rad, Hercules, CA, USA) for 1 h at room temperature. Detection of specific signals was performed using an enhanced chemiluminescence chemiluminescence detection kit (Tanon, Shanghai, China). The density value of each western blot band was analysed by semi-quantitative analysis using Tanon Image (Tanon, China). The protein expression level was normalized to b-actin.
Quantitative real-time PCR
Total RNA was isolated from cells with Trizol reagent (Invitrogen) in accordance with the manufacturer's instructions. Total RNA from each sample was reverse transcribed with random primer using M-MLV (Vazyme). The primers for GAPDH, CYP4Z2P 3 0 -UTR and CYP4Z1 3 0 -UTR were used previously in our laboratory [21, 23] . The primers for the hTERT were: forward, 5 0 -GCTGCTCAGGTCTTTCTTT- of PCR being performed. Melting curve analysis and agarose gel electrophoresis were used routinely to check the amplicon specificity. The gene GAPDH was used as an internal control. Then, the expression of each transcript was calculated using the 2 ÀMMct method.
Statistical analysis
Statistical analyses were performed using PRISM, version 5 (GraphPad Software Inc., San Diego, CA, USA). There were three independent experiments. Statistical significance was tested using Student's t-test to compare the difference of two groups. P < 0.05 was considered statistically significant.
Results
Downregulation of CYP4Z1 or CYP4Z2P 3 0 -UTR promotes breast cancer apoptosis Because our previous study has shown that the levels of CYP4Z1 and pseudogene CYP4Z2P are upregulated in breast cancer [24] , we speculated that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P could inhibit apoptosis. The transfection efficiency was determined in MCF-7 and MDA-MB-231 cells using quantitative real-time PCR (Fig. S1A-C) . siRNA targeting CYP4Z1 or CYP4Z2P 3 0 -UTR was transfected into breast cancer cells, and then cell apoptosis was detected. We found that downregulation of CYP4Z1 or CYP4Z2P 3 0 -UTR promoted apoptosis of breast cancer (Fig. 1A) . The expression of apoptosis-related proteins such as Bcl-2 and Bax was investigated by western blot analysis. A decrease of Bcl-2 and an increase of Bax expression were observed after the transfection of si-Z1 or si-Z2P, and the ratio of Bcl-2/ Bax was significantly decreased (Fig. 1B) , whereas transfection of of Z1-UTR or Z2P-UTR significantly increased the Bcl-2/Bax ratio (Fig. 1C) . These results suggested that downregulation of CYP4Z1 or CYP4Z2P 3 0 -UTR could promote apoptosis. Because our previous study has shown that miR-125a-3p could bind to the 3 0 -UTR of CYP4Z1 and CYP4Z2P, thus inhibiting this ceRNET [21] , we further investigated the role of miR-125a-3p in apoptosis. The miR-125a-3p mimic or inhibitor was transfected into breast cancer cells. miR-125a-3p mimic was shown to promote apoptosis of breast cancer cells (Fig. S2A ) and the quantification data of cleaved-caspase-3 was significantly increased (Fig. S2B) . Taken together, these results confirm that miR-125a-3p holds a promotive effect on apoptosis.
hTERT is physically associated with miR-125a-3p in breast cancer cells
Because studies have shown that hTERT could inhibit apoptosis [9] [10] [11] , we further explored the potential relationship between miR-125a-3p and hTERT in breast cancer cells. Online prediction software (miR-NA.Org; available at: www.microrna.org) predicted that there were two complementary sites for the seed region of miR-125a-3p on the hTERT 3 0 -UTR ( Fig. 2A) . For the luciferase reporter assay, the construct (hTERT-WT or hTERT-MUT) was co-transfected with miR-125a-3p mimic or negative control into 293T cells. miR-125a-3p mimic induced a reduction in relative luciferase expression in hTERT-WT compared to the negative control. However, no difference in the luciferase activity of hTERT-MUT between miR-125a-3p mimic and the control was observed (Fig. 2B) . In addition, miR-125a-3p mimic effectively decreased the mRNA and protein levels of hTERT (Fig. 2C-E) . These results indicate that miR-125a-3p can directly target hTERT in breast cancer cells.
The ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts as a sub-ceRNET for hTERT Because our previous study has shown that miR-125a-3p could target both CYP4Z1 and pseudogene CYP4Z2P, we further investigated whether hTERT expression could be influenced by the ceRNET between CYP4Z1 and pseudogene CYP4Z2P in breast cancer cells. The mRNA and protein levels of hTERT were increased in MCF-7 and MDA-MB-231 cells (Fig. 3A,B) transfecting with Z1-UTR or Z2P-UTR, whereas knockdown of the CYP4Z1 or CYP4Z2P 3 0 -UTR decreased hTERT expression (Fig. 3C,D) . To confirm that the potential cross-talk between this ceR-NET and hTERT is in a 3 0 -UTR dependent manner, MCF-7 and MDA-MB-231 cells were co-transfected with hTERT-WT, as well as Z1-UTR or Z2P-UTR. As shown in Fig. 3E , overexpression of either the Z1-UTR or Z2P-UTR increased the hTERT-WT reporter activity; in contrast, knockdown of the CYP4Z1 3 0 -UTR or CYP4Z2P 3 0 -UTR suppressed the activity of hTERT-WT (Fig. 3F) . To further investigate the miRNA dependency of the sub-ceRNET between CYP4Z1 and pseudogene CYP4Z2P mediated the regulation of hTERT, we co-transfected si-Z1 or si-Z2P with si-Dicer, which is essential for the synthesis of miRNAs, we found the inhibition of si-Z1 and si-Z2P on hTERT expression was attenuated or even reversed (Fig. 3G) . These results indicate the miRNA dependency of the ceRNET regulation through their 3 0 -UTRs. Thus, our results demonstrate that the ceR-NET between CYP4Z1 and pseudogene CYP4Z2P can bind to and antagonize endogenous miRNAs, thereby regulating hTERT expression. Values are the mean AE SD. **P < 0.01, ***P < 0.001 (n = 3, Student's t-test).
The anti-apoptotic function of the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts in a hTERT-dependent manner
To test whether the anti-apoptotic function of the ceR-NET between CYP4Z1 and pseudogene CYP4Z2P was mediated through hTERT expression, we synthesized three siRNAs against hTERT (si-hTERT). The knockdown efficiency was evaluated by quantitative real-time PCR and western blot analyses (Fig. 4A,B) , the knockdown efficiency of si-hTERT1 was up to 80%, which was used for the further experiments. Next, MCF-7 and MDA-MB-231 were co-transfected with Z1-UTR or Z2P-UTR plus si-hTERT for 48 h and cell apoptosis was measured. As shown in Fig. 4C-F , the anti-apoptotic functions of CYP4Z1 3 0 -UTR and CYP4Z2P 3 0 -UTR were reversed when co-transfecting with si-hTERT. The examination of apoptosis-related proteins was consistent with the above result (Fig. 5A) . In addition, the pro-apoptotic effects of si-Z1 or si-Z2P were restored by overexpression of hTERT (Fig. 5B) . A recent study showed that overxepression hTERT could activate AKT and ERK signaling pathways [8] . Consistent with the effects of the hTERT on p-AKT and p-ERK1/2, CYP4Z2P-and CYP4Z1-3 0 -UTR knockdown decreased p-AKT and p-ERK1/2 levels, and these effects were reversed or attenuated when co-transfected with hTERT (Fig. 5C ). These results demonstrate that the anti-apoptotic function of the ceRNET between CYP4Z1 and pseudogene CYP4Z2P relies on hTERT.
Discussion
Breast cancer is the commonest malignancy in women and approximately 1.2 million women suffer from breast cancer worldwide every year [25] . hTERT expression is upregulated in breast cancer [26] and plays a critical role in tumorigenesis through both its telomere-dependent and -independent activity [27] . Mount studies have shown that ectopic expression of hTERT in various types of tumors, including lung cancer [28] and breast cancer [26] . The recent discovery of the novel anti-apoptotic role of hTERT, independent of its telomerase activity, has added a new perspective with respect to re-evaluating antitelomerase and specifically anti-hTERT strategies [29] [30] [31] [32] .
Previous studies have shown that breast cancer tissues or cells exhibit a higher expression level of CYP4Z1 and pseudogene CYP4Z2P [21, 23, 24] . In addition, the ceRNET between CYP4Z1 and pseudogene CYP4Z2P promotes breast cancer angiogenesis [21] and confers tamoxifen resistance in breast cancer [22] . In the present study, we take one step further by confirming the effects of this ceRNET on apoptosis through regulating hTERT expression level via acting as a sub-ceRNET for hTERT in breast cancer.
The present study reports that the ceRNET of CYP4Z1 and pseudogene CYP4Z2P can function as a sub-ceRNET by competitively binding with miR-125a-3p, therefore upregulating the expression of hTERT in breast cancer cells and inhibiting apoptosis. ceRNAs have already been shown to play a role in critical cellular pathways. For example, our group has shown that 3 0 -UTRs of CDH5, HOXD1 and HOXD10 could inhibit breast cancer metastasis by serving as STARD13 ceRNAs [33] and CXCR4 could promote MCF-7 cells proliferation and metastasis by sequestering miR-146a and elevating the expression of other oncogenes [34] . In the present study, we overexpressed and knocked down the CYP4Z1-and CYP4Z2P-3 0 -UTR and detected apoptosis-related proteins, Bcl-2 and Bax. Our results indicate that the ratio of Bcl-2/ Bax was increased after the overexpression of Z1-UTR or Z2P-UTR and vice versa, suggesting an anti-apoptic function in breast cancer. However, the anti-apoptic function was abolished when Z1-UTR or Z2P-UTR was co-transfected with si-hTERT, indicating that the anti-apoptotic function of the ceRNET between CYP4Z1 and pseudogene CYP4Z2P relies on its regulation of hTERT. Furthermore, data from a luciferase reporter assay demonstrated that CPY4Z1, CYP4Z2P and hTERT 3 0 -UTR shared the common miR-125a-3p binding sites and formed a larger ceR-NET to influence apoptosis in breast cancer.
Our previous research has demonstrated that overexpression of the CYP4Z1 3 0 -UTR and CYP4Z2P 3 0 -UTR activated the PI3K/AKT and ERK1/2 pathways [21] , although the definite mechanism responsible for this remains unclear. A recent study showed that endogenous p-AKT and p-ERK bound to endogenous hTERT could be detected in hTERT precipitates by co-immunoprecipitation assays, suggesting that hTERT could activate AKT and ERK pathways by directly binding to p-AKT and p-ERK [8] . Hence, our results demonstrate that CYP4Z1 3 0 -UTR and CYP4Z2P 3 0 -UTR activate the AKT and ERK1/2 pathways by acting as a sub-ceRNET for hTERT (Fig. 5C ). Taken together, the results show that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P acts as a sub-ceRNET to promote CDK3 expression in ER-positive breast cancer by sharing miRNA miR125a-3p binding sites [22] . We propose that CYP4Z1, CYP4Z2P, hTERT and CDK3 may constitute a larger ceRNET with respect to the occurrence and progression of breast cancer. In addition, our previous study showed that there are four other miRNAs (miR-211, miR-197, miR-1226 and miR-204, in addition to miR125a-3p) confirmed to be involved in the sub-ceRNET between CYP4Z1 and pseudogene CYP4Z2P [21] , although only miR-125a-3p was involved in the ceR-NET under investigation. However, it should be noted that miRNA may target many genes and one gene could be targeted by numerous miRNAs, thus forming a complex ceRNET that is centered. Accordingly, we cannot exclude the possibility that there are other miRNAs involved in the ceRNET and this needs to be investigated in future studies. In conclusion, the result of the present study show that the ceRNET between CYP4Z1 and pseudogene CYP4Z2P could inhibit apoptosis in breast cancer. Combined with previous studies showing that this ceRNET could promote angiogenesis [21] and mediate tamoxifen resistance [22] , the results of the present study offer the possibility that manipulation of the ceRNET between CYP4Z1 and pseudogene CYP4Z2P could give rise to novel biomarkers or agents for the treatment or diagnosis of breast cancer.
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Additional Supporting Information may be found online in the supporting information tab for this article: Fig. S1 . Detection of transfection efficiency (A, B) The efficiency of Z1-UTR and Z2P-UTR transfection and CYP4Z1 and CYP4Z2P 3 0 -UTR silencing by siRNA was confirmed by quantitative real-time PCR in MCF-7 and MDA-MB-231 cells. (C) The transfection efficiency of miR-125a-3p mimic/inhibitor were measured by quantitative real-time PCR in MCF-7 and MDA-MB-231 cells. Values are the mean AE SD. *P < 0.05, **P < 0.01, ***P < 0.001 (n = 3, Student's t-test). Fig. S2 . The function of miR-125a-3p on cell apoptosis (A, B) Cell apoptosis was detected after transfection of miR-125a-3p mimic or inhibitor by Annexin V and western blot assays in MDA-MB-231 cells. Values are the mean AE SD. **P < 0.01 (n = 3, Student's t-test).
